Abstract
The dominant research paradigm for Alzheimer’s disease has focused on amyloid-beta plaque removal for over three decades, producing no curative therapy despite billions of dollars of investment. This paper presents the Redirection Hypothesis: a framework that reinterprets amyloid accumulation not as the cause of Alzheimer’s disease but as a late-stage downstream consequence of upstream biological chain failures — in neuroinflammation, epigenetic regulation, mitochondrial function, gut-brain signalling, metabolic health, and sleep-dependent glymphatic clearance — that begin years or decades before the first plaque is detectable.
The framework integrates evidence from twenty-three disciplines and draws on five epidemiological natural experiments (Nigeria versus African Americans, Japanese migration studies, Mediterranean diet populations, the Finnish FINGER trial, and the Guam neurotoxin pathway) to demonstrate that environmental and lifestyle factors modulate Alzheimer’s outcomes independently of genetic predisposition. A multifactorial threshold model is proposed in which the disease emerges when the
cumulative burden of modifiable risk factors exceeds the brain’s compensatory capacity.
A novel dimension of this framework concerns the specific vulnerability of the Default Mode Network (DMN) — the brain system responsible for self-referential thought and the continuous internal narrative — which is Alzheimer’s preferential first target. The author presents a first-person case study of over seven years of sustained DMN deactivation with preserved cognitive and social functioning, suggesting that cognitive diversification through non-DMN-dependent pathways may
reduce both the metabolic vulnerability of DMN structures and the clinical impact of their degradation.
The paper proposes a prevention-oriented model combining population-level blood-based biomarker screening (p-tau217, GFAP, NfL, amyloid-beta 42/40 ratio) from age 45 with structured upstream lifestyle intervention — dietary modification, physical activity, sleep optimisation, stress reduction, metabolic health management, and observational awareness training — rather than post-symptomatic diagnosis and pharmacological treatment. Ten empirically testable research
questions are formulated, and an invitation to institutional research collaboration is extended.
Revelations Beyond Belief 